• About
    • About Us
    • Management Team
    • Board Of Directors
    • Chief Scientific Advisor
  • Science
  • Products
  • News
    • In The Media
    • Press Releases
  • How To Purchase
    • For Patients
    • For Professionals
  • Contact

Shopping cart

close

760-753-5400

PHYSICIAN FINDER
SENTÉ Labs
close
  • About
    • About Us
    • Management Team
    • Board Of Directors
    • Chief Scientific Advisor
  • Science
  • Products
  • News
    • In The Media
    • Press Releases
  • How To Purchase
    • For Patients
    • For Professionals
  • Contact
24 Oct
Press Releases

SENTÉ Appoints Philippe Schaison to Board of Directors

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
SAN DIEGO, Calif., October 24, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced the...

Read more

  • Email
17 Oct
Press Releases

SENTÉ Announces Issuance of a New United States Patent For Heparan Sulfate

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
San Diego, Calif., Oct. 17, 2016 — SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced that the company...

Read more

  • Email
09 Feb
Press Releases

SENTÉ Appoints Laurent Combredet As President & Chief Executive Officer

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
SAN DIEGO, February 9, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment...

Read more

  • Email
05 Feb
Press Releases

SENTÉ Completes $5M Capital Raise

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
Capital To Further Expand Commercial Operations And Broaden Product Portfolio SAN DIEGO, February 5, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based...

Read more

  • Email
05 Nov
Press Releases

SENTÉ Announces Appointment of Michael Brower as Chief Financial Officer

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
SAN DIEGO, Nov. 5, 2014 (GLOBE NEWSWIRE) — SENTÉ a specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycosaminoglycans, today announced the appointment of Michael Brower to...

Read more

  • Email
17 Jun
Press Releases

Senté Inc., Appoints Mireille Gillings, Ph.D. to Its Board of Directors

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
Experienced Biopharmaceutical Industry Executive Adds to the Depth of the Company’s Board SAN DIEGO, June 17, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products...

Read more

  • Email
02 Jun
Press Releases

Sente, Inc. Raises $5M in Series C Financing

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
Capital to Fund Expanded Commercial Operations and Broaden Product Portfolio SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on...

Read more

  • Email
11 Jul
Press Releases

Sente, Inc. Announces the Appointment of Michael York as President and Chief Executive Officer

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
SAN DIEGO, Jul 11, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today the appointment of Michael York as...

Read more

  • Email
24 May
Press Releases

Sente, Inc. Appoints Distinguished Industry Veteran, Magda Marquet, Ph.D. to Its Board of Directors

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
Biotechnology Veteran Brings Deep Industry Expertise SAN DIEGO, May 24, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today that...

Read more

  • Email
14 May
Press Releases

Sente, Inc. Raises $2.1M in Series B Equity Financing

  • December 20, 2018
  • Posted by hydepod
  • Leave a comment
Funding to Support Commercial Operations and Additional Line Extensions to Senté’s Portfolio of Differentiated Skincare Products Based on Glycoproteins SAN DIEGO, May 14, 2013 (GLOBE NEWSWIRE) — Senté, Inc., a privately held cosmeceutical company engaged...

Read more

  • Email
Close
Recent Posts
  • SENTÉ Announces An Exclusive Co-Promotion Partnership With SCIENTIS For The US Launch Of Cyspera®

    SENTÉ Announces An Exclusive Co-Promotion Partnership With SCIENTIS For The US Launch Of Cyspera®

    September 20, 2019
  • SENTÉ Announces New Collaborations with Galderma Laboratories, L.P. and The HydraFacial™ Company

    SENTÉ Announces New Collaborations with Galderma Laboratories, L.P. and The HydraFacial™ Company

    December 11, 2018
  • SENTÉ Appoints Philippe Schaison to Board of Directors

    SENTÉ Appoints Philippe Schaison to Board of Directors

    October 24, 2016
  • SENTÉ Announces Issuance of a New United States Patent For Heparan Sulfate

    SENTÉ Announces Issuance of a New United States Patent For Heparan Sulfate

    October 17, 2016
  • SENTÉ Appoints Laurent Combredet As President & Chief Executive Officer

    SENTÉ Appoints Laurent Combredet As President & Chief Executive Officer

    February 9, 2016


  • Facebook
  • Twitter
  • Email
  • Instagram
  • Pinterest
  • LinkedIn

© 2019 By SENTÉ® Inc. All Rights Reserved. Design & Development by Junto XP. The information available on this web site is provided for informational purposes only. This information is not intended to replace a medical consultation where a physician's judgment may advise you about specific disorders, conditions and or treatment options. We hope the information will be useful for you to become more educated about your health care decisions.
Scroll To Top
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
Accept